CINECA IRIS Institutional Research Information System

PRATESI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.115
AS - Asia 4.044
EU - Europa 2.673
SA - Sud America 856
Continente sconosciuto - Info sul continente non disponibili 490
AF - Africa 228
OC - Oceania 4
Totale 14.410
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.949
IT - Italia 1.230
CN - Cina 1.222
SG - Singapore 1.186
BR - Brasile 679
HK - Hong Kong 605
VN - Vietnam 443
SE - Svezia 285
DE - Germania 210
FI - Finlandia 165
FR - Francia 152
BG - Bulgaria 147
CI - Costa d'Avorio 128
KR - Corea 124
JP - Giappone 115
AT - Austria 97
RU - Federazione Russa 92
GB - Regno Unito 86
CA - Canada 84
IN - India 73
AR - Argentina 70
TR - Turchia 65
BD - Bangladesh 40
MX - Messico 34
PL - Polonia 34
IQ - Iraq 32
EC - Ecuador 29
CH - Svizzera 28
SN - Senegal 28
ES - Italia 25
NL - Olanda 25
CZ - Repubblica Ceca 21
ID - Indonesia 21
UZ - Uzbekistan 17
VE - Venezuela 16
PK - Pakistan 15
UA - Ucraina 14
CL - Cile 13
CO - Colombia 13
CR - Costa Rica 13
MA - Marocco 13
PY - Paraguay 13
ZA - Sudafrica 13
BE - Belgio 11
NG - Nigeria 10
AL - Albania 9
KE - Kenya 9
SA - Arabia Saudita 9
UY - Uruguay 9
DZ - Algeria 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
EG - Egitto 7
IE - Irlanda 7
JM - Giamaica 7
LT - Lituania 7
JO - Giordania 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
HN - Honduras 5
IL - Israele 5
KZ - Kazakistan 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
SY - Repubblica araba siriana 5
AZ - Azerbaigian 4
DK - Danimarca 4
GR - Grecia 4
PH - Filippine 4
PS - Palestinian Territory 4
RS - Serbia 4
BB - Barbados 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
EU - Europa 3
HU - Ungheria 3
IR - Iran 3
KW - Kuwait 3
NI - Nicaragua 3
PA - Panama 3
TH - Thailandia 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
NP - Nepal 2
QA - Qatar 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
GA - Gabon 1
GI - Gibilterra 1
Totale 13.916
Salva come PNG Salva come JPEG
Città #
Ashburn 827
Singapore 652
Hong Kong 598
Shanghai 522
Santa Clara 465
Fairfield 438
Dallas 396
San Jose 369
Milan 282
Woodbridge 274
Houston 205
Chandler 193
Seattle 193
Hefei 172
Council Bluffs 167
Wilmington 165
New York 164
Cambridge 163
Sofia 147
Beijing 143
Los Angeles 140
Ho Chi Minh City 133
Helsinki 132
Abidjan 128
Seoul 122
Pisa 118
Livorno 116
Ann Arbor 109
Tokyo 105
Boardman 93
Vienna 82
Princeton 78
Serra 78
Florence 76
Hanoi 72
Lauterbourg 68
Bremen 61
Munich 61
Lawrence 58
Rome 56
São Paulo 56
Medford 52
Istanbul 42
Frankfurt am Main 39
Redondo Beach 35
London 32
Buffalo 31
San Diego 30
Dakar 28
Rio de Janeiro 26
Warsaw 23
Dong Ket 22
Denver 21
Turku 20
Ogden 19
Ottawa 19
Vicopisano 19
Bern 18
Da Nang 18
Fuzhou 18
Kent 18
Montreal 18
Atlanta 17
Fort Wayne 17
Nuremberg 17
Porto Alegre 17
Tashkent 17
Washington 17
Baltimore 16
Brooklyn 16
Chennai 16
San Giuliano Terme 16
Chicago 15
Salvador 15
Brno 14
Haiphong 14
Mexico City 14
Amsterdam 13
Paris 13
Toronto 13
Belo Horizonte 12
Boulder 12
Des Moines 12
Orem 12
Phoenix 12
Baghdad 11
Biên Hòa 11
Brasília 11
Curitiba 11
Guayaquil 11
Norwalk 11
San Francisco 11
Wuhan 11
Boston 10
Brussels 10
Cascina 10
Quanzhou 10
San José 10
Trento 10
Brantford 9
Totale 9.519
Salva come PNG Salva come JPEG
Nome #
Neurotrophic Activity and Its Modulation by Zinc Ion of a Dimeric Peptide Mimicking the Brain-Derived Neurotrophic Factor N-Terminal Region 552
Alkyne Functionalization of a Photoactivated Ruthenium Polypyridyl Complex for Click-Enabled Serum Albumin Interaction Studies 435
Two mixed valence diruthenium(ii,iii) isomeric complexes show different anticancer properties 259
New copper(II)/cyclic tetrapeptide system that easily oxidizes to copper(III) under atmospheric oxygen 253
Photocytotoxic Pt(iv) complexes as prospective anticancer agents 253
Redefining platinum(IV) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapies 223
A mixed-valence diruthenium(ii,iii) complex endowed with high stability: from experimental evidence to theoretical interpretation 222
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells 221
When ferrocene and diiron organometallics meet: triiron vinyliminium complexes exhibit strong cytotoxicity and cancer cell selectivity 218
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent 213
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 211
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 206
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 188
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies 186
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments 183
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 183
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex 179
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis 178
Antiproliferative properties and biomolecular interactions of three Pd(II) and Pt(II) complexes 178
New gold carbene complexes as candidate anticancer agents 177
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 176
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues 175
Exploring the interaction between a fluorescent Ag(I)-biscarbene complex and non-canonical DNA structures: a multi-technique investigation 175
Design and Solid Phase Synthesis of New DOTA Conjugated (+)-Biotin Dimers Planned to Develop Molecular Weight-Tuned Avidin Oligomers 172
Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues 170
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 167
ESI MS studies highlight the selective interaction of Auranofin with protein free thiols 167
Ruthenium arene complexes with triphenylphosphane ligands: Cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution 166
Role of the (pseudo)halido ligand in ruthenium(ii): p -cymene a-amino acid complexes in speciation, protein reactivity and cytotoxicity 164
Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests 161
The cisplatin/serum albumin system: A reappraisal 160
A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes 159
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study 157
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity 152
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation 150
Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins 150
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 149
The NAMI A-human ferritin system: A biophysical characterization 149
Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS 148
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with a L-alanyl-based ligand 147
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 147
Exploiting the Chemical Diversity of Metal Compounds as a Source of Novel Anti-COVID-19 Drugs 146
Anti-Staphylococcal Activity of the Auranofin Analogue Bearing Acetylcysteine in Place of the Thiosugar: An Experimental and Theoretical Investigation 144
Mass spectrometry and metallomics: stability and binding site location in the Cyt c-CDDP model system 141
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 141
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments 139
Structure of a new stable Cu(III)/cyclopeptide complex by Cu K-edge XAS study 139
Synthesis, Chemical Characterization, and Biological Evaluation of Hydrophilic Gold(I) and Silver(I) N-Heterocyclic Carbenes as Potential Anticancer Agents 138
Oxaliplatin(IV) Prodrugs Functionalized with Gemcitabine and Capecitabine Induce Blockage of Colorectal Cancer Cell Growth - An Investigation of the Activation Mechanism and Their Nanoformulation 138
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 137
The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes 134
Evaluation of Auranofin Loading within Ferritin Nanocages 134
Structural Characterization of a Gold/Serum Albumin Complex 134
Mass Spectrometry and Metallomics: binding site location in the Cyt c-CDDP model system 132
An unprecedented palladium-arsenic catalytic cycle for nitriles hydration 131
Dioxygen oxidation Cu(II) → Cu(III) in the copper complex of cyclo (Lys- d His-βAla-His): A case study by EXAFS and XANES approach 130
Impact of ring size on the copper(II) coordination abilities of cyclic tetrapeptides 129
Reactions of medicinal gold(III) compounds with proteins and peptides explored by electrospray ionization mass spectrometry and complementary biophysical methods 129
Non‐medical applications of inorganic medicines. A switch based on mechanistic knowledge 128
ESI–MS studies of the reactions of novel platinum(II) complexes containing O,O′-chelated acetylacetonate and sulfur ligands with selected model proteins 127
DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors 126
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 125
Ru(CO)x-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells 125
Reevaluating the Mechanistic Insights of α-TOS-Bearing Pt(IV) Anticancer Complexes: A New Perspective from a More In-Depth Knowledge 123
Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety 123
A biophysical study of the interactions of palladium(II), platinum(II) and gold(III) complexes of aminopyridyl-2,2'-bipyridine ligands with RNAs and other nucleic acid structures 122
Pd(II)/1,10-phenanthroline complexes bearing arene ligands: On the role of N- vs O-coordination to tune their cellular activity and binding ability towards DNA and RNA 122
Short-chain oligopeptides with copper(II) binding properties: the impact of specific structural modifications on the copper(II) coordination abilities 121
Computationally enhanced X-ray diffraction analysis of a gold(III) complex interacting with the human telomeric DNA G-quadruplex. Unravelling non-unique ligand positioning 121
Iron Binding in the Ferroxidase Site of Human Mitochondrial Ferritin 120
Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs 118
Protein interactions of dirhodium tetraacetate: a structural study 117
Cytotoxic auranofin analogues bearing phosphine, arsine and stibine ligands: A study on the possible role of the ligand on the biological activity 116
Strategies for the improvement of metal-based chemotherapeutic treatments 115
Synthesis of dicarba-cyclooctapeptide Somatostatin analogs by conventional and MW-assisted RCM: A study about the impact of the configuration at Cα of selected amino acids 114
Native mass spectrometry of human carbonic anhydrase I and its inhibitor complexes 113
Anticancer effects against colorectal cancer models of chloro(triethylphosphine)gold(I) encapsulated in PLGA–PEG nanoparticles 111
Trans-Pd(II) complexes: A different approach for the development of promising anticancer drugs 107
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 104
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 104
Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds 99
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 94
Direct detection of iron clusters in L ferritins through ESI-MS experiments 89
A new stable Copper(III)/Cyclopeptide complex: structural characterization by XANES and EXAFS studies 88
Anticancer diiron vinyliminium complexes: A structure– activity relationship study 81
Hydrophobic gold nanoparticles coupled with fluorescent dyes: A smart tool for optoelectronic applications 79
Structure of a New Stable Cu(III)/Cyclopeptide Complex by Cu K-Edge XAS Study 76
Editorial: Spotlight on Europe - chemical sciences 2023 74
Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates 74
null 71
Is the Next Cisplatin Already in Our Laboratory? 68
null 66
Procedimento catalitico per la preparazione di ammidi 62
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 62
null 55
Mechanistic Fingerprints from Chloride to Iodide: Halide vs. Ammonia Release in Platinum Anticancer Complexes 49
Ligand‐Dependent DNA Binding and Cytotoxicity of Palladium(II) Complexes 41
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 41
null 41
Thiosugar-functionalized gold(I)-NHC complexes as selective anticancer agents for potential targeted therapy 41
Totale 14.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022707 0 23 11 35 138 111 46 26 72 20 67 158
2022/20231.275 130 120 92 97 73 117 35 59 418 39 48 47
2023/20241.063 115 106 144 77 150 161 71 26 19 22 73 99
2024/20253.724 21 100 18 159 305 326 750 161 378 430 394 682
2025/20264.723 266 581 607 693 324 311 612 318 322 350 141 198
2026/2027709 486 223 0 0 0 0 0 0 0 0 0 0
Totale 14.410